The Only Hepatic-Derived Wound Matrix Primed for Cellular Integration
MiroDerm® is a non-crosslinked acellular wound matrix, derived from the highly vascularized porcine liver. It is intended for the management of wounds, including partial and full-thickness wounds; pressure ulcers; chronic vascular ulcers; diabetic ulcers; tunneled, undermined wounds; trauma wounds; drainage wounds; and surgical wounds.
Studies show MiroDerm Biologic Matrix boosts integration and maturation.
|Treatment of Hard-to-heal Diabetic Foot Ulcers With a Hepatic-derived Wound Matrix||Robert Fridman, Payam Rafat, Carl C Van Gils, Deena Horn, Dean Vayser, C Jake Lambert, Jr||Wounds Epub 2020 June 21||Read Here|
|A Pilot Study to Evaluate the Effects of Perfusion-decellularized Porcine Hepatic-derived Wound Matrix on Difficult-to-heal Diabetic Foot Ulcers||Robert Fridman and Jonathan Engelhardt||WOUNDS, October 2017||Read Here|
|ITEM ID||SIZE||TOTAL cm2|
|BLM-200-02-0815||8 x 15 cm||120|
|BLM-200-02-0710||7 x 10 cm||70|
|BLM-200-02-0808||8 x 8 cm||64|
|BLM-200-02-0505||5 x 5 cm||25|
|BLM-200-02-0307||3 x 7 cm||21|
|BLM-200-02-0404||4 x 4 cm||16|
|BLM-200-02-0303||3 x 3 cm||9|
|BLM-200-02-0203||2 x 3 cm||6|
|BLM-200-02-0202||2 x 2 cm||4|
|MiroDerm Fenestrated Plus|
|BLM-200-03-0815||8 x 15 cm||120|
|BLM-200-03-0710||7 x 10 cm||70|
|BLM-200-03-0808||8 x 8 cm||64|
|BLM-200-03-0505||5 x 5 cm||25|
|BLM-200-03-0307||3 x 7 cm||21|
|BLM-200-03-0404||4 x 4 cm||16|
|BLM-200-03-0303||3 x 3 cm||9|
MiroDerm Fenestrated and MiroDerm Fenestrated Plus are processed and stored in a phosphate buffered aqueous solution, packaged in an inner sterile pouch and outer non-sterile pouch, and sterilized with electron beam irradiation. The product comes in a variety of sizes and is intended for use only by trained medical professionals who are familiar with wound procedures and techniques involving the use of a wound matrix. Federal (U.S.A.) law restricts this product to sale by or on the order of a physician.
MiroDerm Biologic Wound Matrix (Fenestrated and Fenestrated Plus) is indicated for the management of wounds, including: partial and full-thickness wounds; pressure ulcers; venous ulcers; chronic vascular ulcers; diabetic ulcers; tunneled, undermined wounds; trauma-wounds (abrasion lacerations, second-degree burns, skin tears); drainage wounds; and surgical wounds (donor sites/grafts, post-Mohs surgery, post-laser surgery, podiatric wound dehiscence).
See IFU for full prescribing information, including indications, contraindications, precautions, potential complications, and recommended application instructions.
Designed for The Management of Advanced Wounds
- Our proprietary perfusion decellularization process results in an open collagen matrix with natural vascular pathways to assist in cellular infiltration and integration
- Offered in 16 different sizes to meet the individual patient’s clinical needs
MiroDerm has natural vascular pathways and an open collagen matrix that facilitates cellular integration and remodeling in the management of advanced wounds.
Our perfusion decellularization technology facilitates rapid access to the whole organ. By cannulating the native vasculature and perfusing a mild detergent solution through the native blood vessels. This is in contrast to immersing the organ as in immersion decellularization.